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Abstract
As a result of recent developments in imaging modalities and wide spread routine medical checkups and screening, more
incidental liver lesions are found frequently on US these days. When incidental liver lesions are found on US, physicians have
to make a decision whether to just follow up or to undergo additional imaging studies for lesion characterization. In order
to choose the next appropriate imaging modality, the diagnostic accuracy of each imaging study needs to be considered.
Therefore, we tried to compare the accuracy of contrast-enhanced multidetector CT (MDCT) and Gd-EOB-DTPA-enhanced
MRI for characterization of incidental liver masses. We included 127 incidentally found focal liver lesions (94 benign and 33
malignant) from 80 patients (M:F = 45:35) without primary extrahepatic malignancy or chronic liver disease. Two radiologists
independently reviewed Gd-EOB-DTPA-enhanced MRI and MDCT. The proportion of confident interpretations for
differentiation of benign and malignant lesions and for the specific diagnosis of diseases were compared. The proportion of
confident interpretations for the differentiation of benign and malignant lesions was significantly higher with EOB-
MRI(94.5%–97.6%) than with MDCT (74.0%–92.9%). In terms of specific diagnosis, sensitivity and accuracy were significantly
higher with EOB-MRI than with MDCT for the diagnosis of focal nodular hyperplasia (FNH) and focal eosinophilic infiltration.
The diagnoses of the remaining diseases were comparable between EOB-MRI and MDCT. Hence, our results suggested that
Gd-EOB-MRI may provide a higher proportion of confident interpretations than MDCT, especially for the diagnosis of
incidentally found FNH and focal eosinophilic infiltration.
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Introduction
Incidental lesions are defined as unexpected abnormalities
found in patients without relevant symptoms [1]. As a result of
recent developments in imaging modalities, more incidental liver
lesions are found during medical examinations. According to
previous reports, incidental liver lesions were found in 10% to
33% of imaging studies and more than 50% of autopsy cases [2,3].
If patients have histories of prior malignancy or chronic liver
disease, a differential diagnosis of metastasis or hepatocellular
carcinoma (HCC) should be performed first. However, in the
general population without prior relevant medical histories, the
differential diagnosis should start at ground zero. As a result,
incidentally found solid liver lesions are frequently difficult to
characterize based on single imaging modalities and require
further imaging or histological confirmation [2,4]. According to a
recent study, the overall diagnostic accuracy for incidentally found
solid liver lesions was 52–66% when using gadolinium-based
contrast-enhanced magnetic resonance (MR) imaging and 52–
53% with contrast-enhanced ultrasound (CEUS) [5].
The recently introduced Gd-EOB-DTPA is a biphasic hepato-
biliary MR contrast agent. Dynamic contrast-enhanced MR
imaging can be performed with other Gd-based extracellular
contrast agents and the hemodynamic or perfusion characteristics
of the lesion can be assessed. Then, the hepatobiliary phase can be
obtained as it undergoes both renal and biliary excretion.
Observation of the hepatobiliary phase can provide histological
and functional information about lesions and may improve the
diagnostic accuracy of focal liver lesions [6]. According to previous
reports, Gd-EOB-DTPA-enhanced MR can provide useful
information not only for the detection of focal liver lesions, but
also for the characterization of benign and malignant focal lesions
in the liver. [7]. Despite the relatively large number of studies
examining the detection and differential diagnosis of specific focal
hepatic lesions on Gd-EOB-DTPA-enhanced MR, there have
been no reports on the diagnostic performance of Gd-EOB-DTPA
for the characterization of incidentally found focal liver lesions.
Therefore, the purpose of our study was to assess the diagnostic
performance of contrast-enhanced computed tomography (CT)
and Gd-EOB-DTPA-enhanced MR for the differentiation of
incidentally found solid liver lesions in patients without known
histories of malignancy or chronic liver disease.
Methods
Patients
Our retrospective study was approved by the institutional
review board of Yonsei University Health System, which issued a
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formal written waiver of informed consent. The inclusion criteria
were as follows: [(1)] patients with incidentally found liver lesions
on any of the imaging studies; and [(2)] patients who underwent 3-
or 4-phase contrast-enhanced CT as well as Gd-EOB-DTPA-
enhanced MRI. We excluded patients with prior histories of
hepatic or extrahepatic malignancy and who regularly underwent
follow-up evaluations because of chronic hepatitis. Simple hepatic
cysts diagnosed using any of the imaging studies were also
excluded during evaluation. Between June 2007 and June 2009,
178 MRIs were performed for the evaluation of incidental liver
masses. Of 178 MRIs, 98 were excluded because of the following:
29 patients were lost to follow-up after imaging and a confirmative
diagnosis was not made; 31 patients lacked 3- or 4-phase dynamic
contrast-enhanced CT; and 38 patients had known histories of
chronic liver disease, although they had no symptoms and had not
undergone any imaging or laboratory screening. Finally, because
there were no patients who had undergone more than 1 MRI, 80
patients (45 men, 35 women; mean age, 53.2 years; range, 29–85
years) with 127 incidentally found liver masses were included in
our study.
The final diagnosis was made by US-guided biopsy (n = 2: 1
cholangiocarcinomas and 1 focal eosinophilic infiltration) and
operation (n= 24: 1 AML, 3 cholangiocarcinomas, 1 embryonal
sarcoma, 1 FNH, 13 HCCs, 2 hemangiomas, 2 inflammatory
myofibroblastic tumor, and 1 schwannoma. The other 101 lesions
were diagnosed by an experienced radiologist who did not
participate in the imaging analysis based on the imaging findings
including CT, MR, US, PET-CT and follow-up imaging of at least
1 year, clinical history and laboratory analysis including blood test,
blood chemistry, and tumor markers. Among focal liver lesions,
focal eosinophilic infiltration, AML, FNH, and HMG were
regarded as benign lesions, whereas cholangiocarcinoma, embry-
onal sarcoma, and HCC were regarded as malignant lesions.
Inflammatory myofibroblastic tumor was classified as a malignant
lesion because it may present with locally aggressive behavior and
can transform into a malignant tumor [8]. The median interval
between CT and MR was 29 days (interquartile range [IQR], 13–
79 days) for benign lesions and 6 days (IQR, 2–18 days) for
malignant lesions.
Ct and Mr Imaging Protocol
CT scans were performed with a 16- or 64-channel multi-
detector CT scanner (Somatom Sensation 16 and Sensation 64;
Siemens Medical Solutions, Forchhein, Germany and Lightspeed
VCT, GE Medical Systems, Milwaukee, WI, USA). First, a
precontrast CT scan was performed before the administration of
contrast media. Contrast media was injected by power injector via
the antecubital vein in the amount of 2 mL/kg for 30 seconds.
Using a bolus tracking technique, the late arterial phase was
performed 18 seconds after the attenuation value reached 100
Hounsfield Unit (HU) at the abdominal aorta. The portal venous
phase and delayed phase were obtained with a scan delay of 30
seconds and 150 seconds after the end of the previous phase.
MRI was performed with a 1.5-T or 3-T MR system (Achieva
1.5T, Philips Medical System, Best, The Netherlands; Tim Trio
3.0T, Siemens Medical Solutions, Forchhein, Germany) including
a double echo T1-weighted gradient-echo image (in-phase/
opposed-phased), respiratory triggered fat-saturated T2-weighted
image, and 3-dimentional gradient echo T1-weighted image.
Contrast-enhanced dynamic images were obtained at 25–35 sec
(arterial phase), 55–65 sec (portal phase), 85–95 sec (equilibrium
phase) and 10 min (hepatobiliary phase) after bolus injection of
Gd-EOB-DTPA, 0.025 mmol/Kg body weight (Primovist, Bayer
Schering Pharma, Berlin, Germany), followed by a saline flush of
15–20 mL, with the injection rate of 2 mL/sec.
Image Analysis
Two radiologists (Y.E.K and Y.E.C with 6 (reviewer 1) and 3
(reviewer 2) years of experience in abdominal imaging) indepen-
dently reviewed the CT and MR images in separate sessions. The
interval between the two reading sessions was 1 month to avoid
recall bias. All images were evaluated with a picture archiving and
communication system (Centricity; GE Healthcare) without any
patient information. In each session, reviewers were asked to
evaluate whether the lesion was benign or malignant and to grade
the confidence level on a six-point scale: 1, definitely benign; 2,
probably benign; 3, possibly benign; 4, possibly malignant; 5,
probably malignant; 6, definitely malignant. A diagnosis of a
benign or malignant lesion was recorded as being correct when the
reviewer diagnosed a benign lesion as benign with a confidence
level of less than 2 or a malignant lesion as malignant with a
confidence level of more than 5. Then, the reviewers were asked to
provide the most appropriate diagnosis for each focal liver lesion.
The confidence level of each specific diagnosis was graded on a
five-point scale: 1, very unlikely; 2, unlikely; 3, likely; 4, very likely;
5, definitely [5]. A confidence level of 4 or 5 was regarded as being
a correct diagnosis.
Statistical Analysis
The diagnostic accuracy was calculated and compared between
CT and MR with a generalized estimating equation method.
Sensitivity, specificity and accuracy of specific diagnosis were
calculated and compared between CT and MR by a generalized
estimating equation method or weighted least squares method for
repeated categorical data analysis. The agreement between CT
and MR and interobserver variability between reviewers were
calculated by weighted kappa statistics [9]. Statistical analysis was
performed by a biostatistician using SAS (version 9.1.3, SAS
Institute Inc., Cary, NC, USA). Differences with P values less than
0.05 were considered statistically significant.
Results
Diagnostic Performance
For the diagnostic accuracy of differentiation between benign
and malignant lesions, CT showed an accuracy of 92.9% (95%
confidence interval [CI]: 85.8–96.6) for reviewer 1 (R1) and 74.0%
(95% CI: 61.7–83.5) for reviewer 2 (R2). With MR, the accuracy
was 97.6% (95% CI: 92.8–99.3) for R1 and 94.5% (95% CI: 88.0–
97.6) for R2. The diagnostic accuracy for the differentiation of
benign and malignant lesions was significantly different between
CT and MR for R2 (P,0.001), but not for R1 (P=0.050),
although the P value was marginal for the latter. Between
reviewers, the diagnostic accuracy was significantly different for
CT (P,0.001), but not for MR (P=0.136).
In terms of diagnostic performance for specific types of lesions,
MR showed greater sensitivity than CT for the diagnosis of FNH
by R1 (P= 0.010) and focal eosinophilic infiltration by both
reviewers (P=0.020 for R1 and P,0.001 for R2) (Table 1). The
accuracy of detection for specific diseases was significantly higher
with FNH for both reviewers and focal eosinophilic infiltration for
R2. Specificity was 100% for all four common lesions. For the
diagnosis of relatively uncommon lesions, the sensitivities and
specificities are summarized in Table 2.
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Inter- and Intra-Observer Variability
The weighted kappa value was 0.556 (95% CI: 0.478–0.634) for
CT and 0.637 (95% CI: 0.568–0.706) for MR between R1 and
R2. Between CT and MR, the weighted kappa value was 0.822
(95% CI: 0.746–0.897) for R1 and 0.609 (95% CI: 0.536–0.682)
for R2.
Descriptive Analysis of Uncertain and Missed Diagnoses
Of 55 hemangiomas, 1 lesion had an uncertain diagnosis (i.e.,
diagnosed as hemangioma with a confidence level of 3) from both
reviewers (Table 3). This lesion showed peripheral dot-like
enhancement, but central fill-in enhancement was not noted.
Among 27 FNH, 3 lesions were misdiagnosed by both reviewers
on CT. One lesion was misdiagnosed as AP shunt on CT by both
reviewers, but diagnosed correctly as FNH on MR (Figure 1).
Another lesion was misdiagnosed as AML by both reviewers on
CT, but diagnosed as FNH on MR with a confidence level of 4
and 3. This lesion showed high signal intensity on HBP of MR.
The last of the three misdiagnosed FHNs was diagnosed as
hemangioma and HCC on CT by both reviewers, respectively.
This lesion showed early heterogeneous enhancement in the
arterial phase and persistent enhancement on the portal venous
CT and MR images. On HBP of MR, the peripheral portion of
the lesion showed high signal intensity, but the central portion
showed low signal intensity compared with the adjacent liver
parenchyma. This lesion was diagnosed as adenoma with a
confidence level of 3 and FNH with a confidence level of 4 on MR
by both reviewers.
Two HCC were misdiagnosed by both reviewers. One was
misdiagnosed as FHN on CT by both reviewers because the lesion
showed homogenous arterial enhancement without definite
delayed washout. On MR, the lesion presented with low signal
intensity compared with the adjacent liver on HBP and was
diagnosed as HCC with a confidence level of 4 by both reviewers.
The other HCC was diagnosed as HCC on CT by both reviewers
with a confidence level of 4 (R1) and 3 (R2), but was misdiagnosed
on MR as FNH with a confidence level of 5 (R1) and 3 (R2). This
lesion showed high signal intensity on HBP and was confirmed as
Table 1. Sensitivity and accuracy of common lesions.
Reviewer 1 Reviewer 2
Sensitivity P value Accuracy P value Sensitivity P value Accuracy P value
Hemangioma
(n = 45)
CT 86.7% (66.9–95.4) 0.058 95.3% (87.4–98.3) 0.063 75.6% (56.5–88.0) 0.054 91.3% (83.1–95.8) 0.068
MR 97.8% (85.3–99.7) 99.2% (94.6–99.9) 86.7% (66.9–95.4) 95.3% (87.4–98.3)
FNH (n = 27) CT 66.7% (41.6–84.9) 0.010 92.9% (86.6–96.4) 0.017 37.0% (14.2–67.6) 0.060 86.6% (75.3–93.2) 0.045
MR 96.3%
(76.9–99.5)
99.2% (94.6–99.9) 77.8% (57.4–90.1) 95.3% (88.8–98.1)
HCC (n = 24) CT 95.8% (74.8–99.4) 0.231 99.2% (94.6–99.9) 0.236 79.2% (56.8–91.6) 0.716 96.1% (90.7–98.4) 0.715
MR 83.3% (56.3–95.1) 96.9% (90.0–99.1) 83.3% (64.4–93.3) 96.9% (90.4–99.0)
FEI* (n = 15) CT 66.7% (31.0–89.9) 0.020 96.1% (89.3–98.6) 0.083 0% ,0.001 88.2% (76.3–94.6) 0.029
MR 93.3% (62.4–99.2) 99.2% (94.6–99.9) 66.7% (5.3–96.6) 96.1% (89.3–98.6)
Numbers in parentheses are the 95% confidence interval.
*FEI indicates focal eosinophilic infiltration.
doi:10.1371/journal.pone.0066141.t001
Table 2. Sensitivity and accuracy of relatively uncommon lesions.
Reviewer 1 Reviewer 2
Sensitivity Specificity Sensitivity Specificity
Focal fat deposition CT 2/3 124/124 1/3 124/124
MR 2/3 124124 2/3 124/124
AML CT 1/3 122/124 0/3 123/124
MR 2/3 124/124 2/3 124/124
Schwannoma CT 0/1 126/126 0/1 126/126
MR 0/1 126/126 0/1 126/126
Cholangiocarcinoma CT 6/6 121/121 3/6 121/121
MR 6/6 117/121 6/6 121/121
Inflammatory myofibroblastic tumor CT 0/2 125/125 0/2 125/125
MR 0/2 125/125 0/2 125/125
Embryonal sarcoma CT 0/1 126/126 0/1 126/126
MR 0/1 126/126 0/1 126/126
doi:10.1371/journal.pone.0066141.t002
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well-differentiated HCC (Edmonson grade I) by surgery
(Figure 2).
Two focal eosinophilic infiltrations were misdiagnosed by both
reviewers. One lesion was misdiagnosed as hemangioma by R1
(confidence level of 3) and cholangiocarcinoma by R2 (confidence
level of 3). This lesion was diagnosed as focal eosinophilic
infiltration with a confidence level of 4 on MR by both reviewers.
The other lesion was misdiagnosed as peliosis by R1 (confidence
level of 3) and cholangiocarcinoma by R2 (confidence level of 3)
both on CT and MR.
Discussion
Our results demonstrate that Gd-EOB-DTPA-enhanced MR
provides better diagnostic accuracy for the differentiation of
benign and malignant lesions and for the specific diagnosis of FNH
and focal eosinophilic infiltration. Both dynamic contrast-en-
hanced CT and Gd-EOB-DTPA-enhanced MR had similarly
high diagnostic performances for hemangioma and HCC, whereas
relatively uncommon lesions such as inflammatory myofibroblastic
tumor, schwannoma or embryonal sarcoma were rarely diagnosed
accurately on both CT and MR.
According to a previous study, about 37% of patients with
incidental lesions that were found on whole body CT scans during
medical checkups received at least one recommendation for
further evaluation [4]. Several guidelines have been suggested for
radiologists or clinicians when they encounter incidental liver
lesions [1,2]. But these guidelines cannot be applied uniformly
because disease epidemiology varies according to geographic area
and medical history or conditions vary between patients. When
incidental liver lesions are found, the main role of the physician is
either to make an appropriate diagnosis without performing
unnecessary procedures or to recommend the next appropriate
diagnostic step. In our results, Gd-EOB-DTPA MR showed a
similar diagnostic performance to contrast-enhanced MDCT for
most incidental liver lesions, although statistical significance was
only noted in the diagnosis of FHN and focal eosinophilic
infiltration. Furthermore, radiation exposure is not needed during
MR, hence patients who are vulnerable to radiation exposure,
such as children, young females or pregnant women, MR is a
more appropriate imaging study for the diagnosis of incidental
liver lesions. However these results do not suggest that MR is
always superior to MDCT for characterization of incidental liver
lesions. This is because CT evaluates not only the liver but also
other abdominal solid organs, hollow viscous, peritoneal cavities
and even basal lungs in one examination. Examination time is also
much shorter in CT than in MR, which is important to patients
who have claustrophobia. Hence CT and MR should be chosen
case by case, based on clinical situations.
In our study, inter-observer agreement between CT and MR
was higher for the more experienced radiologist than for the less
experienced radiologist, and intra-observer agreement between
CT and MR was higher for the more experienced radiologist than
for the less experienced radiologist. These results suggest that more
experienced radiologists could diagnose incidentally found liver
masses both on CT and MR, whereas less experienced radiologists
might diagnose incidental liver lesions more accurately and
confidently on MR than on CT.
According to a previous study, CEUS could correctly differen-
tiate benign from malignant lesions in about 96.5% of cases and
yield a correct specific diagnosis in 52%–73% of cases [5,10]. It
was also reported that CEUS showed comparable diagnostic
performance with Gd-chelate contrast-enhanced MR for inciden-
tal liver lesions [5]. CEUS also has merits in that it does not
involve radiation exposure, requires a shorter exam time than
MR, and is relatively less expensive than CT and MR. But CEUS,
like conventional gray-scale US, is operator-dependent, requires a
Table 3. Uncertain or misdiagnosed cases.
Uncertain
diagnosis Misdiagnosis
CT MR CT MR
Hemangioma both 1 1 0 0
R1 0 0 5 0
R2 10 5 0 0
FNH both 3 0 3 0
R1 0 0 3 1
R2 14 6 0 0
HCC both 0 0 1 1
R1 0 0 0 3
R2 3 2 1 1
FEI both 1 0 2 1
R1 2 0 0 0
R2 10 4 2 0
doi:10.1371/journal.pone.0066141.t003
Figure 1. 73-year-old female with incidental liver mass. (a) Arial phase CT image shows ill-defined hypervascular lesion in segment 8 of the
liver (arrow). (b) The lesion shows isoattenuation on portal venous phase and both reviewers diagnosed this lesion as arterioportal shunt on CT with a
confidence level of 4 and 3, respectively. (c) However, this lesion presented with high signal intensity compared to the adjacent normal liver on
hepatobiliary phase of MR image (arrow). The diagnosis was changed to FNH on MR with a high confidence level of 5 by both reviewers.
doi:10.1371/journal.pone.0066141.g001
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dedicated US sequence and is limited in some regions because the
US contrast agent is still not commercially available. Furthermore,
the diagnostic performance of CEUS in the previous study might
be overestimated because less than 10% of the included incidental
liver lesions were malignant and most of the malignant lesions
were diagnosed with uncertainty [5,10].
Hepatic hemangioma could be diagnosed accurately both on
CT and MR because it usually presents with typical imaging
findings of peripheral globular enhancement with gradual central
fill in [2]. However, slow enhancing hemangioma might present as
a low attenuating lesion even in the delayed phase and could be
diagnosed as hypovascular metastasis or cystic lesion on CT [11].
Early and persistent enhancing hemangioma could be misdiag-
nosed as a hypervascular tumor such as HCC or neuroendocrine
carcinoma on CT and even on MR because hemangioma might
manifest as a relatively low SI compared to the adjacent normal
liver parenchyma, which uptakes Gd-EOB-DTPA during the
equilibrium phase, i.e., pseudo-washout sign [12]. Findings with
high signal intensity on T2-weighted MR image could be helpful
for diagnoses of hemangioma with atypical enhancement patterns
[11]. According to previous studies, MR showed better accuracy
for the diagnosis of hemangioma than CT (84% for MR versus
73% for CT) [13]. Our result was compatible with that of a
previous study, where the sensitivity and accuracy were higher on
MR (sensitivity: 86.7–97.8%, accuracy: 95.3%–99.2%) than on
CT (sensitivity: 75.6%–86.7%, accuracy: 91.3%–95.3%), although
there was no statistically significant difference.
According to previous reports, Gd-EOB-DTPA-enhanced MRI
(88.1%) showed superior diagnostic performance in comparison
with contrast-enhanced CT (84.7%) or non-enhanced MR
(67.8%) for the diagnosis of FNH [14]. FNH usually presents
with hypervascular nodules on the arterial phase that return to iso-
attenuation or iso-signal intensity on portal venous or equilibrium
phase images [14]. However, this enhancement pattern is not
sufficient for the diagnosis of FNH, especially in small lesions,
because other lesions such as HCC, hypervascular metastasis, and
adenoma could be manifested in this way. Tortuous feeding vessels
and central scars might be helpful for the diagnosis and MR could
show central scars more clearly because of its high tissue contrast.
Furthermore, the hepatobiliary phase on Gd-EOB-DTPA-en-
hanced MR could give additive information since FNH usually
presents with high- or iso-SI compared with the adjacent liver on
the hepatobiliary phase [14,15]. As a result, MR may have had a
higher sensitivity and accuracy than CT for the diagnosis of FNH
in our study.
Gd-EOB-DTPA-enhanced MR showed comparable or better
diagnostic performance for the diagnosis of HCC than contrast-
enhanced CT, gadopentetate dimeglumine-enhanced MR imag-
ing [16,17]. The study samples of previous studies included
patients with chronic liver disease or liver cirrhosis. If HCC
develops in the cirrhotic liver and information such as serum alpha
fetoprotein level and clinical history are given to the radiologist,
HCC could be easily diagnosed. Incidentally found HCC is often
diagnosed correctly or might be diagnosed as HCC with a lower
confidence level because it frequently presents as a large dominant
mass and is accompanied by calcification, hemorrhage, a fat
component, dilated intrahepatic bile duct, and abdominal
lymphadenopathy, which are not common findings for typical
HCC that develops in the cirrhotic liver [18]. Furthermore, a
hypervascular nodule on arterial phase images with a high signal
intensity on hepatobiliary phase MR image might easily be
misdiagnosed as FNH, especially in patients with non-cirrhotic
liver. In our study, one HCC was diagnosed correctly as HCC on
CT, but misdiagnosed as FNH on MR by both reviewers because
the lesion showed high signal intensity on the hepatobiliary phase.
In this case, a hepatobiliary phase MR image would actually
interfere with the diagnosis.
In terms of focal eosinophilic infiltration, it has been reported
that portal phase CT image shows better lesion-to-liver contrast
than that of Gd-chelate contrast-enhanced MR image [19].
However, recently used Gd-EOB-DTPA-enhanced MR offers
better lesion-to-liver contrast on portal venous or equilibrium
phase MR images than CT or Gd-chelate-enhanced MR images
because about 50% of the contrast medium is taken up by
hepatocytes, resulting in increased signal intensity of the normal
liver parenchyma [20]. In our study, the sensitivity for diagnosis of
focal eosinophilic infiltration was only 0%–66.7% on CT.
However, most of the diagnoses were not misdiagnoses, but
rather, diagnoses with a lower confidence level (i.e. confidence
level less than 3). This might be because the reviewers were
blinded to information other than CT images, such as peripheral
eosinophil count, which is very informative for the diagnosis of
focal eosinophilic infiltration [20]. On MR, the sensitivity
increased to 66.7%–93.3%. Although metastasis cannot always
be differentiated from focal eosinophilic infiltration, enhancement
patterns and the margin of the lesion, which is homogenous or
shows rim enhancement on arterial phase, and low-attenuation or
low-signal intensity on the delayed- and hepatobiliary-phase with
ill-defined margin could be helpful findings for differential
Figure 2. 50-year-old man presented incidental liver mass. (a) On arterial phase CT image, faint arterial enhancing nodule is noted in the left
lobe of the liver. (b) The lesion shows slightly low attenuation compared to adjacent liver on delayed CT image. Both reviewers diagnosed the lesion
as HCC with a confidence level of 4 and 3 on CT. (c) On MR, the lesion showed high signal intensity on the hepatobiliary phase and the diagnosis was
changed to FNH by both reviewers, but the lesion was confirmed as well-differentiated HCC by surgery.
doi:10.1371/journal.pone.0066141.g002
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diagnosis and these findings could be more clearly depicted on Gd-
EOG-DTPA-enhanced MR than CT [20].
For the less common lesions, especially inflammatory myofi-
broblastic tumor, schwannoma and embryonal sarcoma, none
were diagnosed correctly by both reviewers. Because of the rarity
of these lesions, it is hard to accurately diagnose them in almost all
cases, although they might be included in the differential diagnosis.
In contrast, focal fat deposition and cholangiocarcinoma could be
diagnosed properly on CT or MR because of their specific
locations or typical imaging findings. In terms of AML, if it
presents with a gross fat component, it can be diagnosed directly as
AML or as one of the differential diagnoses including fat-
containing liver tumors such as lipomas or HCC with fatty
metamorphosis.
There are several limitations of our study. First, this study was
retrospective. Second, we evaluated incidental liver lesions based
only on imaging findings, although clinical findings including
physical examination, laboratory test, age and gender are also
important and helpful for differential diagnosis. Third, we
excluded patients with prior histories of malignancy or chronic
hepatitis. In these patients, it might be more difficult to
differentiate metastasis or HCC from other benign or malignant
lesions.
In conclusion, for the characterization of incidental liver masses,
Gd-EOB-DTPA-enhanced MR provides better diagnostic accu-
racy than CT for the differentiation of benign and malignant
lesions and for the specific diagnosis of FNH and focal eosinophilic
infiltration.
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